Exact Mass: 326.97562700000003
Exact Mass Matches: 326.97562700000003
Found 58 metabolites which its exact mass value is equals to given mass value 326.97562700000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Diloxanide
C14H11Cl2NO4 (327.00651060000007)
Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections. Although it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
7-Bromo-1-(1H-pyrrol-2-yl)-9H-pyrido(3,4-b)indol-6-ol
1,2-Dichloro-6,8-dihydroxy-7-propyl-9H-pyrrolo[2,1-b][1,3]benzoxazine-9-one
C14H11Cl2NO4 (327.00651060000007)
6-Deamino-6beta-iodo-6-Aminopenicillanic acid
C8H10INO3S (326.94261400000005)
Bifenox free acid
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 8453
3-chloro-4-(dimethylamino)benzenediazonium,hexafluorophosphate
ethyl 3-(2-carboxy-vinyl)-4,6-dichloro-1h-indole-2-carboxylate
C14H11Cl2NO4 (327.00651060000007)
3,11-Dichloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide
C14H11Cl2NO2S (326.98875260000005)
(Z)-4-(4-BROMOBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
n-succinimidyl ferrocenecarboxylate
C15H13FeNO4 (327.01939280000005)
3-[5-(4-chloro-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-propionic acid
N-(3-iodo-4-methylphenyl)furan-3-carboxamide
C12H10INO2 (326.97562700000003)
2,5-Dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)benzenamine
4-(3-chloro-2-cyanophenoxy)benzenesulfonyl chloride
Cytidine 2,3-cyclic phosphate
Cytidine 2,3-cyclic phosphate is a cytidine nucleotide containing a pyrophosphate group esterified to C2 and C3(cyclic) of the sugar moiety. A cyclic nucleotide is any nucleotide in which the phosphate group is bonded to two of the sugars hydroxyl groups, forming a cyclical or ring structure. 2,3 cyclic CMP is a substrate for 2,3-cyclic-nucleotide 3-phosphodiesterase (EC 3.1.4.37). This enzyme (also called CNP) catalyzes the chemical reaction: nucleoside 2,3-cyclic phosphate + H2O <-> nucleoside 2-phosphate. CNP is a myelin-associated enzyme that makes up 4\\% of total CNS myelin protein, and is thought to undergo significant age-associated changes. The absence of CNP causes axonal swelling and neuronal degeneration. The biological role of cyclic 2,3 monophosphates is not clear, although it is thought to have something to do with neuronal stasis or development. [HMDB]
Methyl 5-chloro-N-(methoxycarbonylmethyl)-3-sulfamoylthiophene-2-carboxylate
C9H10ClNO6S2 (326.96380700000003)
Ammonium ((1S,3R,4R,7S)-3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]heptan-7-yl)methanesulfonate
(R)-TERT-BUTYL (4,4-DIBROMOBUT-3-EN-2-YL)CARBAMATE
C9H15Br2NO2 (326.94694499999997)
5-chloro-7-bromo-8-quinolyl vinyl carbonate
C12H7BrClNO3 (326.9297802000001)
5-iodo-7-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline
2,6-dichloro-N-(2,4-dinitrophenyl)aniline
C12H7Cl2N3O4 (326.98136020000004)
2-(2,2,2-TRIFLUOROACETYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONYL CHLORIDE
5-(4-chloro-phenylsulfamoyl)-2-hydroxy-benzoic acid
5-(4-IODO-PHENYL)-2-ISOPROPYL-2H-PYRAZOL-3-YLAMINE
6-[(2-chloroquinolin-3-yl)methyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one
C16H10ClN3OS (327.02330800000004)
3-Chloro-N-(3-fluoro-4-broMophenyl)benzaMide
C13H8BrClFNO (326.94617800000003)
5-[(2-Chlorophenyl)sulfamoyl]-2-hydroxybenzoic acid
2-[(5-Chloro-1-benzothiophen-3-yl)methyl]-1H-isoindole-1,3(2H)-di one
C17H10ClNO2S (327.01207500000004)
Iodohippurate Sodium I-131
V - Various > V09 - Diagnostic radiopharmaceuticals > V09C - Renal system C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
Iodohippurate Sodium I-123
V - Various > V09 - Diagnostic radiopharmaceuticals > V09C - Renal system C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
6-Iodopenicillanic acid
C8H10INO3S (326.94261400000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams D004791 - Enzyme Inhibitors
4,5-Dihydroxydiclofenac
C14H11Cl2NO4 (327.00651060000007)
A monocarboxylic acid that is the 4,5-dihydroxylated metabolite of diclofenac.
Iodohippurate sodium i-125
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
6-bromo-3-[(E)-3-chloroprop-2-enyl]-2-methyl-1H-quinoline-4-thione
C13H11BrClNS (326.94840560000006)
4-Thiazolidinone, 2-(2,6-dichlorophenyl)-3-(2-furanylmethyl)-
C14H11Cl2NO2S (326.98875260000005)
ethyl N-[(2Z)-2-cyano-2-{[(2,4-dichlorophenyl)amino]methylidene}acetyl]carbamate
4,5-Dioxo-4,5-dihydro-1H-pyrrolo[2,3-F]quinoline-2,7,9-tricarboxylate
2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide
DILOXANIDE FUROATE
C14H11Cl2NO4 (327.00651060000007)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
ZL006
C14H11Cl2NO4 (327.00651060000007)
ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.